Molecular Biology

M.P. Kamps, C. Murre, X.-h. Sun, D. Baltimore, "A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in Pre-B ALL," Cell, 60:547- 55, 1990. Mark Kamps (University of California, San Diego): "In man, most chromosomal translocations elicit tumorigenic effects by introducing a strong enhancer adjacent to a normal cellular gene, such as c-MYC, and constitutively activating its expression. Less frequently, a chimeric oncogene forms by the joining of two distinc

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

M.P. Kamps, C. Murre, X.-h. Sun, D. Baltimore, "A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in Pre-B ALL," Cell, 60:547- 55, 1990.

Mark Kamps (University of California, San Diego): "In man, most chromosomal translocations elicit tumorigenic effects by introducing a strong enhancer adjacent to a normal cellular gene, such as c-MYC, and constitutively activating its expression. Less frequently, a chimeric oncogene forms by the joining of two distinct genes within their coding sequences, ultimately producing a fusion protein in which critical regulatory functions are altered or deleted.

"This paper describes the molecular result of the t(1;19) chromosomal translocation, which combines both of these oncogenic mechanisms, inducing the expression of the normally silent PBX1 homeobox gene in pre-B cells by appending its 3e homeobox encoding sequences to the 5e transactivator encoding sequences of the E2A gene. The implication that both the transactivation domain of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies